0.05Open2.00Pre Close1 Volume29 Open Interest65.00Strike Price5.00Turnover0.00%IV0.85%PremiumMay 17, 2024Expiry Date0.60Intrinsic Value100Multiplier-1DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma1288.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Globus Medical Stock Discussion
with all the WHAM BANG SLAM sports, basketball,football,soccer, plenty of people are going to need muscoskeleton implants/bone replacements. seems like they got the parts for every bone n joints.
$Bank of America(BAC.US)$ $Pioneer Natural Resources(PXD.US)$ $Uber Technologies(UBER.US)$ $Futu Holdings Ltd(FUTU.US)$ $PDD Holdings(PDD.US)$ $CVS Health(CVS.US)$ $Advanced Micro Devices(AMD.US)$ $ParkwayLife Reit(C2PU.SG)$ $AMC Entertainment(AMC.US)$ $Palantir(PLTR.US)$ $Meta Platforms(META.US)$ $3M(MMM.US)$ $ARK Innovation ETF(ARKK.US)$ $Direxion Daily S&P Biotech Bull 3x Shares ETF(LABU.US)$ $Coinbase(COIN.US)$
$Tesla(TSLA.US)$ $PDD Holdings(PDD.US)$ $Coinbase(COIN.US)$ $AbCellera Biologics(ABCL.US)$ $Boston Scientific(BSX.US)$ $Thermo Fisher Scientific(TMO.US)$ $Apple(AAPL.US)$ $Rivian Automotive(RIVN.US)$ $NIO Inc(NIO.US)$ $XPeng(XPEV.US)$ $ParkwayLife Reit(C2PU.SG)$ $Advanced Micro Devices(AMD.US)$ $3M(MMM.US)$
• $Rocket Pharmaceuticals(RCKT.US)$ +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
• $Canada Goose(GOOS.US)$ +9.4% (the company reported an unexpected profit as well as better-than-expected revenue)
• $SIGA Technologies(SIGA.US)$ +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...
• $A10 Networks(ATEN.US)$ +10.6% (to join S&P SmallCap 600)
• $SVB Financial(SIVB.US)$ +8.9% (earnings report)
• $Revance Therapeutics(RVNC.US)$ +8.9% (FDA accepts BLA resubmission for DaxibotulinumtoxinA for Injection)
• $UFP Industries(UFPI.US)$ +5.9% (also increases dividend)
• $JD.com(JD.US)$ +3.8% (weighing payment of special cash dividend)
• $Establishment Labs(ESTA.US)$ +3.4% (Presentation of 2-Year Results from Motiva US...
No comment yet